Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury

Experimental Physiology

Volumn 97, Issue 1, 2012, Pages 89-101

  Qi, Yanfei ^a   Li, Hongwei ^c   Shenoy, Vinayak ^a   Li, Qiuhong ^b   Wong, Fong ^a   Zhang, Ling ^c   Raizada, Mohan K ^a   Sumners, Colin ^a   Katovich, Michael J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE; ENHANCED GREEN FLUORESCENT PROTEIN; GENOMIC DNA; MESSENGER RNA; PARVOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; HEMODYNAMIC MONITORING; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; WESTERN BLOTTING;

EID: 84355162846     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.060673     Document Type: Article

References (49)

1. Anavekar NS & Solomon SD (2005). Angiotensin II receptor blockade and ventricular remodelling. J Renin Angiotensin Aldosterone Syst 6, 43-48.
2. Booz GW & Baker KM (1996). Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28, 635-640.
3. Booz GW, Dostal DE & Baker KM (1999). Paracrine actions of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin-angiotensin system. Am J Cardiol 83, 44H-47H.
4. 2 receptors in the mouse heart. Hypertension 46, 937-942.
5. D'Amore A, Black MJ & Thomas WG (2005). The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46, 1347-1354.
6. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ & Raizada MK (2008). Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 51, 712-718.
7. Gerc V & Buksa M (2010). Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases. Med Arh 64, 295-299.
8. Grobe JL, Der Sarkissian S, Stewart JM, Meszaros JG, Raizada MK & Katovich MJ (2007). ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clin Sci (Lond) 113, 357-364.
9. Gurzu B, Costuleanu M, Slatineanu SM, Ciobanu A & Petrescu G (2005). Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein? J Renin Angiotensin Aldosterone Syst 6, 90-95.
10. 2 angiotensin receptor gene expression in human heart failure. Circulation 95, 1201-1206.
11. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB & Ferrario CM (2004). Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43, 970-976.
12. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX & Greenberg BH (2005). Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289, H2356-H2363.
13. Jiang XY, Gao GD, Du XJ, Zhou J, Wang XF & Lin YX (2007). The signalling of AT2 and the influence on the collagen metabolism of AT2 receptor in adult rat cardiac fibroblasts. Acta Cardiol 62, 429-438.
14. Jugdutt BI & Menon V (2004). AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat. Mol Cell Biochem 262, 203-214.
15. Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F et al. (2008). Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118, 2523-2532.
16. Le Corvoisier P, Adamy C, Sambin L, Crozatier B, Berdeaux A, Michel JB, Hittinger L & Su J (2010). The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice. Eur J Heart Fail 12, 1171-1178.
17. Li H, Gao Y, Grobe JL, Raizada MK, Katovich MJ & Sumners C (2007). Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor. Am J Physiol Heart Circ Physiol 292, H727-H735.
18. Li H, Qi Y, Li C, Braseth LN, Gao Y, Shabashvili AE, Katovich MJ & Sumners C (2009). Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Mol Cancer Ther 8, 3255-3265.
19. Matsubara H (1998). Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83, 1182-1191.
20. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92, 10663-10667.
21. Nakayama M, Yan X, Price RL, Borg TK, Ito K, Sanbe A, Robbins J & Lorell BH (2005). Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction. Am J Physiol Heart Circ Physiol 288, H317-H327.
22. Nio Y, Matsubara H, Murasawa S, Kanasaki M & Inada M (1995). Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95, 46-54.
23. Oishi Y, Ozono R, Yano Y, Teranishi Y, Akishita M, Horiuchi M, Oshima T & Kambe M (2003). Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension 41, 814-818.
24. Oishi Y, Ozono R, Yoshizumi M, Akishita M, Horiuchi M & Oshima T (2006). AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life Sci 80, 82-88.
25. Ozono R, Matsumoto T, Shingu T, Oshima T, Teranishi Y, Kambe M, Matsuura H, Kajiyama G, Wang ZQ, Moore AF & Carey RM (2000). Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart. Am J Physiol Regul Integr Comp Physiol 278, R781-R789.
26. Pfeffer MA & Braunwald E (1990). Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161-1172.
27. Qi Y, Liu X, Li H, Shenoy V, Li Q, Hauswirth WW, Sumners C & Katovich MJ (2010). Selective tropism of the recombinant adeno-associated virus 9 serotype for rat cardiac tissue. J Gene Med 12, 22-34.
28. Qi Y, Shenoy V, Wong F, Afzal A, Mocco J, Sumners C, Raizada MK & Katovich MJ (2011). Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia- induced cardiac pathophysiology. Exp Physiol 96, 863-874.
29. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, Steffen C, Hidebrandt A, Hetzer R & Fleck E (1995). Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91, 1461-1471.
30. Stacy LB, Yu Q, Horak K & Larson DF (2007). Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities. Perfusion 22, 51-55.
31. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R & Unger T (1995). The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95, 651-657.
32. Su H, Huang Y, Takagawa J, Barcena A, Arakawa-Hoyt J, Ye J, Grossman W & Kan YW (2006). AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Gene Ther 13, 1495-1502.
33. Tesanovic S, Vinh A, Gaspari TA, Casley D & Widdop RE (2010). Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30, 1606-1613.
34. Tiyyagura SR & Pinney SP (2006). Left ventricular remodeling after myocardial infarction: past, present, and future. Mt Sinai J Med 73, 840-851.
35. Trask AJ, Averill DB, Ganten D, Chappell MC & Ferrario CM (2007). Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. Am J Physiol Heart Circ Physiol 292, H3019-H3024.
36. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M & Iwasaka T (1998). Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 83, 1035-1046.
37. van Kesteren CA, van Heugten HA, Lamers JM, Saxena PR, Schalekamp MA & Danser AH (1997). Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 29, 2147-2157.
38. Wang LJ, He JG, Ma H, Cai YM, Liao XX, Zeng WT, Liu J & Wang LC (2005). Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats. Di Yi Jun Yi Da Xue Xue Bao 25, 481-487.
39. Weber KT & Brilla CG (1991). Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83, 1849-1865.
40. 2 receptors in the normal and failing human heart. J Pharmacol Exp Ther 284, 323-336.
41. Williams RS & Benjamin IJ (2000). Protective responses in the ischemic myocardium. J Clin Invest 106, 813-818.
42. Woo YJ, Zhang JC, Taylor MD, Cohen JE, Hsu VM & Sweeney HL (2005). One year transgene expression with adeno-associated virus cardiac gene transfer. Int J Cardiol 100, 421-426.
43. Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ & Horiuchi M (1998). Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci 63, PL289-PL295.
44. Yan X, Price RL, Nakayama M, Ito K, Schuldt AJ, Manning WJ, Sanbe A, Borg TK, Robbins J & Lorell BH (2003). Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice. Am J Physiol Heart Circ Physiol 285, H2179-H2187.
45. Yang Z, Bove CM, French BA, Epstein FH, Berr SS, DiMaria JM, Gibson JJ, Carey RM & Kramer CM (2002). Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 106, 106-111.
46. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML & Lakatta EG (1982). Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol Heart Circ Physiol 243, H941-H947.
47. Yu L, Zheng M, Wang W, Rozanski GJ, Zucker IH & Gao L (2010). Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst 11, 214-221.
48. Zhu YZ, Chimon GN, Zhu YC, et al. (2000). Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats. Neuroreport 11, 1191-1194.
49. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR & Canver CC (2003). Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 108, 1707-1712.